Ce site Web utilise des cookies afin que nous puissions vous offrir la meilleure expérience utilisateur possible. Les informations des cookies sont stockées dans votre navigateur et remplissent des fonctions telles que vous reconnaître lorsque vous revenez sur notre site Web et aider notre équipe à comprendre quelles sections du site Web vous trouvez les plus intéressantes et utiles.
Publications
2024
J.R. Yeo m, et al., Asymmetric Engagement of Dimeric CRL3KBTBD4 by the Molecular Glue UM171 Licenses Degradation of HDAC1/2 Complexes
Lire la suite2024
Chagraoui J, et al., KBTBD4-mediated Reduction of MYC Is Critical For Hematopoietic Stem Cell Expansion Upon UM171 Treatment, Blood
Lire la suite2022
Fares I, et al., Decoding Human Hematopoietic Stem Cell Self-Renewal, Current Stem Cell Reports (2022)
Lire la suite2022
Carvalho VS et al., UM171 Expands immature bone marrow CD34+ Cells From Patients With Telomeropathies, Hematology, Transfusion and Cell Therapy
Lire la suite2022
Salame N et al., UM171-induced ROS promote antigen cross-presentation of immunogenic peptides by bone marrow-derived mesenchymal stromal cells, Stem Cell Research & Therapy
Lire la suite2021
Chagraoui J, et al., UM171 Preserves Epigenetic Marks that Are Reduced in Ex Vivo Culture of Human HSCs via Potentiation of the CLR3-KBTBD4 Complex, Cell Stem Cell
Lire la suite2021
David R. Liu et al., Base editing of haematopoietic stem cells rescues sickle cell disease in mice, Nature
Lire la suite2020
Capo V, et al., Expanded circulating hematopoietic stem/progenitor cells as novel cell source for the treatment of TCIRG1 osteopetrosis, Haematologica
Lire la suite2019
Chagraoui J, et al., UM171 induces a homeostatic inflammatory-detoxification response supporting human HSC self-renewal, PloS ONE
Lire la suite2018
Porteus M et al., Priming Human Repopulating Hematopoietic Stem and Progenitor Cells for Cas9/sgRNA Gene Targeting, Molecular Therapy, Nucleic Acids
Lire la suite2018
Ngom M, et al., UM171 Enhances Lentiviral Gene Transfer and Recovery of Primitive Human Hematopoietic Cells, Molecular Therapy, Methods & Clinical Development
Lire la suite2014